Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 644326Generated: October 31, 2026

1-(Piperidin-4-yl)-4-(propan-2-yl)piperazine → 4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidine-1-carboxylic acid-{(R)-1-(3,4-diethyl-benzyl)-2-[4-(4-isopropyl-piperazin-1-yl)-piperidin-1-yl]-2-oxo-ethyl}-amide

https://huagongshe.com/reaction/644326

Reaction equation

Participants

RoleNameHCIDCharge
Reactant1-(Piperidin-4-yl)-4-(propan-2-yl)piperazineHCID 28283030—
Reactant(R)-3-(3,4-diethyl-phenyl)-2-{[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidine-1-carbonyl]-amino}-propionic acidHCID 68579001—
Product4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidine-1-carboxylic acid-{(R)-1-(3,4-diethyl-benzyl)-2-[4-(4-isopropyl-piperazin-1-yl)-piperidin-1-yl]-2-oxo-ethyl}-amideHCID 10439596—

Reaction Steps

Prepared analogously to Example 9i) from 400 mg (0.81 mmol) (R)-3-(3,4-diethyl-phenyl)-2-{[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidine-1-carbonyl]-amino}-propionic acid and 210 mg (0.99 mmol) 1-isopropyl-4-piperidin-4-yl-piperazine.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07700589B2
Source datasetuspto-grants-2010_04
ORD IDord-8fcc42019c2049278addcac2c27a29c9
Source noteuspto-grants-2010_04